UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20369

 

FORM 8-K

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of Earliest Event Reported): December 19, 2019

 

NATURAL HEALTH FARM HOLDINGS INC
(Exact name of registrant as specified in charter)

 

Nevada   000-1621697   98-1032170
         

(State or Other Jurisdiction

of Incorporation)

 

(Commission File

Number)

 

(IRS Employer

Identification No.)

 

No. 48 & 49, Jalan Velox 2   48000
Taman Velox, Rawang Industrial Park    
48000 Rawang, Selangor, Malaysia    
(Address of principal executive offices)   (Zip code)

 

  +60(3) 6091 6321  
  (Registrant's telephone number including area code)  

 

  100 Challenger Road, Suite 831, Ridgefield Park, NJ 40150                    
  (Former Name or former address, if changed since last report)  

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001 per share   NHEL   OTC Markets Group

  

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  o

 

 

  
 

   

Item 5.02         Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

Resignation of Officers and Directors

 

On December 19, Mr. Tee Chuen Hau submitted his resignation as Chief Financial Officer of the Company effective immediately. Mr. Hau’s resignation is not a result of any disagreement with the Company, and the Company thanks Mr. Hau for his contributions to the Company. Subsequently, on December 19, 2019, the Board appointed Mr. Tee Chuen Meng as Chief Financial Officer of the Company. Mr. Meng is currently the CEO of the Company. 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: December 26, 2019    
     
Natural Health Farm Holdings Inc    
     
/s/ Tee Chuen Meng    
     
Mr. Tee Chuen Meng    
Chief Executive Officer